Allergan (United States)

99.1k citations
2.2k papers ·

Impact in

Papers in

    • Glaucoma and retinal disorders 257
    • Retinal Diseases and Treatments 142
    • Botulinum Toxin and Related Neurological Disorders 258
    • Neurological disorders and treatments 81

Allergan (United States)

2.0k papers receiving 86.8k citations

Peers

Allergan (United States)
Comparison fields: 5 of 220
  • Ophthalmology 19.5k
  • Psychiatry and Mental health 15.3k
  • Urology 4.5k
  • Neurology 9.7k
  • Dermatology 5.2k
Replace May Institute with:
May Institute United States
St. Elizabeth's Medical Center United States
Centre hospitalier de l'Université Laval Canada
Alfred I. duPont Hospital for Children United States
Institute of Clinical Research United States
Lawson Health Research Institute Canada
Covance (United States) United States
Lankenau Institute for Medical Research United States
Center for Vascular Biology Research United States
Hunter Holmes McGuire VA Medical Center United States
Allergan (United States) relative to May Institute United States May Institute's profile →
Citations per field
00.5×5×10.5×
May Institute · 1×
Citations per year

Countries citing scholars working at Allergan (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Allergan (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Allergan (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allergan (United States) more than expected).

Fields of papers published by authors at Allergan (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Allergan (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Allergan (United States) at the time of their publication.

About Allergan (United States)

In recent decades, authors affiliated with Allergan (United States) have published 2.2k papers, which have received a total of 99.1k indexed citations . Scholars at this organization have produced 420 papers in Ophthalmology, 270 papers in Neurology, 235 papers in Psychiatry and Mental health, 144 papers in Dermatology and 92 papers in Urology on the topics of Botulinum Toxin and Related Neurological Disorders (258 papers), Glaucoma and retinal disorders (257 papers), Ocular Surface and Contact Lens (212 papers), Migraine and Headache Studies (164 papers), Retinal Diseases and Treatments (142 papers), Retinoids in leukemia and cellular processes (86 papers), Urinary Bladder and Prostate Research (83 papers) and Neurological disorders and treatments (81 papers). Their work is cited by papers focused on Ophthalmology (19.5k citations), Psychiatry and Mental health (15.3k citations), Urology (4.5k citations), Neurology (9.7k citations) and Dermatology (5.2k citations). Authors at Allergan (United States) collaborate with scholars in United States, Ireland and United Kingdom and have published in prestigious journals including Investigative Ophthalmology & Visual Science, Dermatologic Surgery, Neurology, Toxicon and Ophthalmology. Some of Allergan (United States)'s most productive authors include Michael Ethan Stern, Richard B. Lipton, Stephen Carl Pflugfelder, Scott M. Whitcup, Roshantha A.S. Chandraratna, Kei Roger Aoki, Mitchell F. Brin, Catherine C. Turkel, Dawn C. Buse and David F. Woodward.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact